What is recurrent glioblastoma?
‘Glioblastoma’ is a type of aggressive advanced-stage brain tumour, starting from cells called astrocytes. A Grade IV tumour according to World Health Organization, it is also often referred to as glioblastoma multiforme (GBM). When cancer returns after a period of remission, it is called as recurrent cancer. GBM is likely to recur. Research shows that more than 90% of patients with glioma show recurrence at the original tumour location To know more, click here.
What causes Glioblastoma?
It is not conclusively and clearly known as to what the risk factors of glioblastoma could be, this being a very infrequent type of tumour. Some factors may be derived from common features identified in a few reported glioblastoma patients, click here.
How is glioblastoma treated?
Treatment plan for glioblastoma involves a combination of approaches. So far, the standard-of-care for GBM has been maximal safe surgical removal of cancer, followed by radiotherapy and chemotherapy with temozolomide (TMZ), an oral alkylating chemotherapy agent. Bevacizumab is a monoclonal antibody, used for the treatment of recurrent glioblastoma. To know more on treatment, click here.
What are the symptoms of glioblastoma?
Most of the reported symptoms of glioblastoma are felt because of the fast growing mass of tumour itself and/or from the fluid surrounding the tumour. Reported symptoms include frequent headaches and drowsiness, nausea, vomiting, and severe headaches that are typically worse in the morning, sensory changes of face, arm or leg, balance difficulties etc. To read more on symptoms, click here.